ArticleAnnals of translational medicine2020

Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression.

Qiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.